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A b s t r a c t  
Biopolymers are used as vehicles for the carrying drugs to their site of action. These polymers are 
less toxic and can even protect the drug entity from degradation in physiological conditions of the 
body. Large number of techniques are employed to prepare the nanoformulation of these polymers 
but ionic gelation is of great interest because no harsh and incompatible chemicals are used during 
the process. Chitosan nanoparticles are good drug carriers because of their good biocompatibility 
and biodegradability. As a new drug delivery system they have attracted attention due to their 
applications in loading protein, drugs etc.  In the present research ionic gelation technique have 
been optimized for the preparation of chitosan nanoparticles. Various physico-chemical parameters 
of Nanoparticles such as size, Zeta potential and poly dispersity index were evaluated under 
different process parameters.  
In current study onic gelation technique had been optimized for the preparation of chitosan 
nanoparticles. We have evaluated the effect of various physico-chemical parameters such as type of 
polyanion, Sonication, surfactant etc and their effect on size and zeta potential of nanoparticles had 
been studied. 
A novel Nanoparticle system composed of low molecular weight chitosan was successfully prepared 
in the present study by simple ionic-gelation techniques under aqueous-based conditions. It was 
observed that there was considerable effect of various physico- chemical parameters on size, zeta 
potential and polydispersity index of Nanoparticles prepared. Result shows that the size of 
Nanoparticles decreases with the increase in concentration of Chitosan. Polyvinyl alcohol was found 
to be the best surfactant because it was very effective in decreasing the surface tension without 
increasing viscosity. Intermittent sonication during the process decreases the size of Nanoparticles 
considerably. Controlled use of polyanions under different conditions can develop negatively 
charged Nanoparticles that can be used for delivery of positively charged drugs and therapeutic 
molecules. 
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Introduction 
Nanotechnology facilitates innovative biomedical solutions at 
molecular level. Drug delivery is one of the rising innovations of 
Nanoscience [1]. The use of recombinant proteins as therapeutics 
is known but these proteins and peptides have very limited storage 
stability, high immunogenicity and low efficacy due to lack of proper 
delivery systems [2]. Besides this proteins and peptides are poorly 
absorbed after oral administration due to low permeation across 
intestinal epithelium and susceptibility to enzymatic degradation. 
Many of the drugs are poorly absorbed across the mucosal 
surfaces but encapsulation of these drugs in biopolymeric carriers 
can prevent the degradation of these drugs in hostile environment  
 
 
of gastro intestinal tract [3]. Nanoparticles modify the 
pharmacokinetics and pharmacodynamics of drug and protects 
drugs from hydrolytic enzymes in gastrointestinal tract. [4]. 
Hydrophilic nanoparticles have received considerable attention to 
deliver wide variety of therapeutic drugs , peptides, oligonucleotide 
and genes by intravenous, oral and mucosal administration[5]. NPs 
have gained much attention because they have mucoadhesive 
properties, biodegradable, less toxic, higher loading capacity, 
enhanced interaction sites due to large surface to volume ratio and 
long shelf life. A wide variety of matrices arebeing used for the 
preparation of nanoparticles such as Chitosan[6] Cyclodextrins[7], 
Ceramics[8], Emulsions[9], Quantum dots[10] , Gold shell 
nanoparticles[11]. Some nanomaterials, such as ultra fine TiO2. 
Ultra fine cadmium oxide, Single walled carbon nanotubes, 
Ultrafine nickel, Single walled carbon nanotubes & silver 
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nanoparticles may be toxic to living systems [12-16] and may 
cause oxidative stress and some are reported to be potent 
carcinogens[17]. Since metallic nanomaterials may have toxic 
effects hence non-toxic and biodegradable nanomaterials are the 
materials of choice. Chitosan has received considerable attention 
as a material for the formation of NPs[18] as it helps in controlled 
drug release, increases drug solubility and stability, enhances drug 
loading efficiency, reduces toxicity, biocompatible and 
biodegradable [18] mucoadhesive, efficient intestinal permeation 
enhancer[19, 20]. CS is copolymer containing β (1,4)-2-acetamido-
D-glucose and β-(1,4)-2-amino-D-glucose unit. Plant extract loaded 
Chitosan Nanoparticles were found to have immunorestorative 
properties [21]. It possesses positive charge due to presence of 
surface amine groups. It actively binds negatively charged siailc 
acid residues on mucous membranes and enhances drug release 
profile of the drug.It was also reported to enhance intestinal 
permeation across intestinal epithelial cell line Caco-2 [22]. The 
principle behind the mechanism of formation of NPs includes the 
electrostatic interaction between both oppositely charged 
polysaccharides with the ability of CS to undergo a liquid gel 
transition because of its ionic interaction with poly anions such as 
Trisodium polyphosphate [24]. It is used as excellent protein 
delivery system [23], gene delivery systems [24] and carrier for 
nasal vaccines [25].The residual amine groups present on the 
surface of Chitosan after gelation, interact with negatively charged 
drugs.  
Hence in present study, Chitosan has been employed for 
formulation of nanoparticles and effect of various physico-chemical 
parameters on mean diameter of nanoparticles were studied. The 
charge of drug affects considerably the uptake of the drug in acidic 
environment produced by tumor cells due to excessive 
consumption of oxygen. Negatively charged drugs such as 
camptothecinisup taken by tumor tissue efficiently but weakly basic 
and positively charged drugs were excluded [26] .Hence the 
present study was also done to optimize ionic gelation  process for 
chitosan nanoparticle formulation and to  broaden the application of 
CS NPÊs in delivery of both positively and negatively charged drugs 
by altering surface charge using different poly anions. 
Materials and methods  
Optimization of process parameters for preparation of 
Chitosan Nanoparticles 
 In present study, four different methods differing in various physico 
chemical aspects had been used for the preparation of Chitosan 
Nanoparticles.  Ionic gelation technique was used for preparation 
of NPs. The method followed was a modification of the Janes et 
al.[27]  The effect of various physico chemical parameters on the 
characterstics Chitosan Nanoparticles obtained were studied. 
These process parameters affects the mean diameter  and zeta 
potential of the CS particles obtained. 
Method 1: 0.17 % (W/V) chitosan was dissolved distilled water 
acidified with 2% acetic acid.2% tween 80 was added as a 
surfactant to prevent aggregation of nanoparticles .The solution 
was stirred over magnetic stirrer at 500 rpm for 48 hours without 
ultrasonication. After 48 h sodium sulphate was added slowly to the 
solution with continued stirring for 1 h to precipitate Chitosan 
nanoparticles from the solution. Temperature was maintained at 
37ĈC during the process. 
Lyophilizationof Chitosan nanoparticles 
The CS NPs prepared by method 1 were lyophilized. 1% mannitol 
was used as cryoprotectant. During primary drying process solvent 
is first removed by sublimation by maintaining the temperature 
below eutectic temperature of nanoparticles suspension. Primary 
drying is followed by secondary drying process to remove residual 
moisture to prevent growth of microorganism and chemical 
reactions. Lyophilized cultures were stored at 4À C in deep freezer 
for a month.   
Method 2: Chitosan (0.05% w/v) was dissolved in 2% acetic acid 
and solution was stirred using magnetic stirrer at 25°C. Prepared 
0.1% (w/v) sodium hexametaphosphate solution  in distilled water 
and added it in chitosan solution at a rate of 1 mL/min till the 
transmittance of the suspension reaches up to 75% at an operating 
wavelength of  480 nm. The whole solution was sonicated for 20 
mins. 1% PVA was added to stabilize the particle suspension. The 
Chitosan Nanoparticles were characterized by diffraction light 
scattering using Zeta Sizer (Malvern Co.) 
Method 3: 0.1 % (W/V) chitosan was dissolved in distilled water 
containing 2% Acetic acid. The resulting solution was agitated 
using magnetic stirrer at 500 rpm at 37°C for 4h. Chitosan 
Nanoparticles were precipitated with 0.5 % Sodium 
hexametaphosphate. Sodium hexametaphosphate was added drop 
wise with uninterrupted stirring till the transmittance of the solution 
becomes 75%.Ultrasonication was not done during entire process. 
The nano particle suspension was stabilized by drop wise addition 
of 0.5% (W/V) polyvinyl alcohol as surfactant. 
Method 4: 0.1 % (W/V) chitosan was dissolved in distilled water 
containing 2% Acetic acid. The resulting solution was stirred gently 
over magnetic stirrer at 500 rpm at 37°C for 4h. Chitosan nano 
particles were precipitated with 0.5 % Pentasodium 
Tripolyphosphate (TPP). TPP was added drop wise with 
uninterrupted stirring till the transmittance of the solution becomes 
75%. Ultrasonication was not done during entire process. The nano 
particle suspension was stabilized by drop wise addition of 0.5% 
(W/V) polyvinyl alcohol as surfactant. 
Results and Discussion 
Method 1:The average size of Chitosan nanoparticles was found to 
be 1275 nm (Figure 1) with Polydispersity Index of 0.474. The Zeta 
Potential was recorded to be +16.7 mV (Figure 2) 
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Figure 6 : Zeta Potential of Chitosan Nanoparticles by method 2: 
 
and Zeta potential of the chitosan nanoparticles was recorded to be 
-12.2 mV which is found to be quite significant (figure 6) The 
polydispersity index was 0.334 showing monodisperse nature of 
Nanoparticles. 
METHOD 3: The size of nanoparticles was found to be 6711 nm 
(figure 7) and Zeta potential of the chitosan nanoparticles was 
recorded to be -21.1 mV (figure 8). 
 
 
Figure 7 : Size of Chitosan Nanoparticles obtained  by method 3: 
 
 
Figure 8 : Zeta Potential of Chitosan Nanoparticles obtained by 
method 3 
 
The negative zeta potential was observed may be due to 
negatively charged phosphate groups in Sodium 
hexametaphosphate. The polydispersity index was 0.454 showing 
that maximum nanoparticles are having the size of 6711 nm and 
process results are within significant limits. 
METHOD 4: The size of nanoparticles was found to be 5621 nm 
(figure 9) and Zeta potential of the chitosan nanoparticles was 
recorded to be +2.34 mV (figure 10).  
 
 
Figure 9 : Size of Chitosan Nanoparticles obtained  by method 4 
 
 
Figure 10 : Zeta Potential of Chitosan Nanoparticles obtained by 
method 4 
 
The polydispersity index was found to be 1.000 showing the 
process exceeds the prescribed limit of PDI and hence process is 
insignificant because Chitosan Nanoparticles synthesized were 
polydisperse in nature and have very narrow utility as therapeutic 
carriers. 
The various parameters such as concentration of CS, sonication, 
type of polyanion and surfactant used in the process have been 
studied in relation to the acceptability of CS NPs. 
Effect of Chitosan concentration 
It has been found that with the increase in concentration of 
chitosan, the size of nanoparticles increases. 0.05% chitosan gave 
best results. This may be due to the fact that at higher 
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concentration CS molecules are present in close vicinity to each 
other and they got precipitated to form a large particle during 
precipitation by polyanion. 
Effect of polyanion 
The zeta potential was dependent upon the type of polyanion used 
during the preparation of CS NPs. When sodium sulphate and TPP 
were used for precipitation of NPs, the zeta potential was recorded 
to be +16.7mV. The positive zeta potential is may be due to 
surface residual amine groups present in chitosan. But when 
sodium hexametaphosphate is used as polyanion for precipitation 
of Chitosan nanoparticles, the zeta potential was found to be -
21.1mV. The negative zeta potential is may be due to the 
excessive phosphate groups remained un-interacted during the 
process. 
Effect of surfactant 
PVA was found to be better surfactant as compared to Tween-80. 
It may be due to the fact that PVA was more efficient in reducing 
the surface tension. Besides this, Tween-80 was found to be more 
viscous than PVA.  
Effect of Sonication 
Sonication affected the mean diameter of Chitosan NPs to 
considerable extent. It is possibly due to shear forces that reduced 
the mean diameter of Nanoparticles during the process. 
Effect on properties of Chitosan Nanoparticles upon 
long term storage in lyophilized form. 
CS NPs were lyophilized and stored for one month at 4 ÀC. These 
nanoparticles were resuspended in phosphate buffer and Dynamic 
Light Scattering analysis revealed that no considerable change in 
size and zeta potential occurs after long term storage. Hence these 
Nanoparticles can be stored lyophilized but in aqueous 
suspension, they swell in size and degrade gradually.  
 
Conclusion 
In the present study, attempts were made to optimize method for 
preparation of chitosan nanoparticles. Chitosan nanoparticles was 
successfully prepared in the study by a simple ionic-gelation 
method under aqueous-based conditions Results revealed that 
there is considerable effect of chitosan concentration, surfactant, 
Sonication and polyanionon the mean diameter and zeta potential 
of Nanoparticles obtained. Size of Nanoparticles stored for one 
month at low temperature increased upon Lyophilization to some 
extent but zeta potential remained the constant. Hence it is 
possible to store therapeutics for longer duration without the loss of 
efficacy of drugs. The negatively charged Chitosan Nanoparticles 
obtained can be employed for delivery of poorly absorbed 
positively charged drugs. Hence charge on Nanoparticles can be 
altered according to the nature of drug and application of Chitosan 
Nanoparticles can be broadened as drug delivery vehicles. 
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